INSMED INC Other Current Liabilities
INSMED INC (INSM) had Other Current Liabilities of $0 as of 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2021-02-25
- 2020-12-31: Other Liabilities, Current $0.00.
- 2020-09-30: Other Liabilities, Current $0.00.
- 2020-06-30: Other Liabilities, Current $0.00.
- 2020-03-31: Other Liabilities, Current $78.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-10-29 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 |
| 2020-03-31 | $78.00K 10-Q · filed 2020-04-30 |
| 2019-12-31 | $280.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $130.00K 10-Q · filed 2019-10-30 |
| 2019-06-30 | $234.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $82.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.53M 10-K · filed 2020-02-25 |
| 2018-09-30 | $472.00K 10-Q · filed 2018-10-30 |
| 2018-06-30 | $630.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $556.00K 10-Q · filed 2018-05-02 |
| 2017-12-31 | $646.00K 10-K · filed 2019-02-22 |
| 2017-09-30 | $616.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $694.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $674.00K 10-Q · filed 2017-05-03 |
| 2016-12-31 | $728.00K 10-K · filed 2018-02-23 |
| 2016-09-30 | $647.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $716.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $686.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $683.00K 10-K · filed 2017-02-23 |
| 2015-09-30 | $682.00K 10-Q · filed 2015-11-06 |
| 2015-06-30 | $701.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $716.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | $743.00K 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |